NorthPoint Clients Gain Access To ConvergEx's Institutional-Strength Technologies

Feb 24 2010 | 4:13pm ET

ConvergEx Group, a provider of investment and execution technology solutions for institutional clients, has announced that clients of the firm’s prime brokerage business, NorthPoint Trading Partners, now have access to ConvergEx’s institutional strength commission management technologies and soft dollar services. 

“Since joining the ConvergEx family, NorthPoint’s clients are beginning to see a tremendous expansion of the technology and investment services that are available to them,” said Douglas Nelson, chief executive officer of NorthPoint. “By rolling out ConvergEx’s industry-leading commission management technologies to our clients, we are providing immediate access to state-of-the-art commission management reporting and administration as well as enhanced security for their commission balances.”

ConvergEx is one of the largest providers of commission management services to the investment community. In November, the ConverEx acquired NorthPoint for an undisclosed sum.

“We’re pleased to offer our complete suite of neutral, anonymous and transparent services to NorthPoint’s clients,” said John Meserve, executive managing director of ConvergEx Group. “Our team of experts has in-depth knowledge of the key issues affecting clients and the tools we provide will simplify and manage their commission workflow from broker vote all the way through third-party payments.”


In Depth

MiFID2 For U.S. Firms: Key Questions Answered

Feb 27 2017 | 4:54pm ET

The January 2018 deadline for implementation of the EU’s mammoth MiFID2 regulations...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

iCapital Network: The Trump Effect On Direct Lending

Feb 23 2017 | 4:21pm ET

The arrival of the Trump Administration has raised questions among private debt...

 

From the current issue of